SomaLogic announced an agreement with the U.S. Food and Drug Administration’s (FDA) Division of Applied Regulatory Science to evaluate the utility of large-scale analysis of proteins (proteomics) for the identification of biomarkers that may be useful ...
SomaLogic to analyze ~5000 proteins in each of at least 15,000 clinical samples from Janssen to identify & validate protein biomarkers for use to treat diseases...